CKD inhospital patients(eGFR<
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: *Patients who are over 20 years old at the time of obtaining informed consent *The patient gave document agreement with the free will of himself, after receiving a sufficient explanation on participation in this study and on top of full understanding by himself.
Exclusion criteria
Exclusion criteria: *Patients receiving dialysis *Patients having any cancer *Patients who have difficulty with pessing upper arm in mentally or physically *Patients who don't give the consent of the participants to the test *Patients whom the principal investigator judged to be inappropriate as a subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| *Change of creatinine level in acute and chronic phases before and after of the CI treatment *Change of the urinary L-FABP level(CIN or not) | — |
Secondary
| Measure | Time frame |
|---|---|
| MACE(death,cardiac infarction,target vessel retreatment: Having RIPC or not, Are there difference having CIN or not?, microglobulin in the urine, erythropoietin in the blood : Mechanism of CIN onset, Guess the mechanism of the effect of RIPC) | — |
Countries
Japan
Contacts
Osaka General Medical Center Cardiac internal medicine